<i>(R)</i> -2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in <i>IDH</i> -Mutant CancersKathryn Gunn(Dana-Farber Cancer Institute), Julie-Aurore Losman(Brigham and Women's Hospital)Cancer DiscoveryFebruary 27, 202310.1158/2159-8290.cd-22-0825Cited by 41SaveCiteExport RISWatch citationsRelated PapersSecondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma|npj Precision Oncology|2022|77Low-frequency inherited complement receptor variants are associated with purpura fulminans|Blood|2023|9Rare Inherited Defects of the Complement System in Purpura Fulminans|Blood|2020|2Pathway-based Rare Variant Burden Analysis Identifies a Role for the Complement System in an Extreme Phenotype of Sepsis with Coagulopathy|medRxiv|2022|2